These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 27273939)

  • 21. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
    Ginnebaugh KR; Ahmad A; Sarkar FH
    Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
    Sato R; Semba T; Saya H; Arima Y
    Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic cancer stem cells: emerging target for designing novel therapy.
    Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
    Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
    Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
    Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation, identification, and characterization of cancer stem cells: A review.
    Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M
    J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.
    Foroni C; Broggini M; Generali D; Damia G
    Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis.
    Lei ZN; Teng QX; Koya J; Liu Y; Chen Z; Zeng L; Chen ZS; Fang S; Wang J; Liu Y; Pan Y
    Front Immunol; 2024; 15():1417201. PubMed ID: 39403386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.
    Zubeldia IG; Bleau AM; Redrado M; Serrano D; Agliano A; Gil-Puig C; Vidal-Vanaclocha F; Lecanda J; Calvo A
    Exp Cell Res; 2013 Feb; 319(3):12-22. PubMed ID: 23153552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
    Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
    Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epithelial-mesenchymal transition and cancer stem cells].
    Zou DD; Tang XB
    Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):62-5. PubMed ID: 23611281
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.
    Celià-Terrassa T; Jolly MK
    Cold Spring Harb Perspect Med; 2020 Jul; 10(7):. PubMed ID: 31570380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial-to-mesenchymal-like transition events in melanoma.
    Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
    FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tackling the cancer stem cells - what challenges do they pose?
    Pattabiraman DR; Weinberg RA
    Nat Rev Drug Discov; 2014 Jul; 13(7):497-512. PubMed ID: 24981363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. At the crossroads of cancer stem cells and targeted therapy resistance.
    Wang A; Qu L; Wang L
    Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms promoting physiological cells progression into tumorigenesis.
    Korbut E; Ptak-Belowska A; Brzozowski T
    J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A roadmap toward total elimination of cancer].
    Okamoto K; Nakagama H
    Nihon Rinsho; 2015 May; 73(5):860-5. PubMed ID: 25985644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.
    Fedele M; Sgarra R; Battista S; Cerchia L; Manfioletti G
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.